
---
title: '首个预防癌症的疫苗 默沙东确认2022年增加中国市场HPV疫苗供应'
categories: 
 - 新媒体
 - 快科技（原驱动之家）
 - 最新新闻
headimg: 'https://img1.mydrivers.com/img/20220111/d59a6e9e-c224-4cb5-8e1b-412ea8fbcf9c.png'
author: 快科技（原驱动之家）
comments: false
date: Tue, 11 Jan 2022 13:52:57 GMT
thumbnail: 'https://img1.mydrivers.com/img/20220111/d59a6e9e-c224-4cb5-8e1b-412ea8fbcf9c.png'
---

<div>   
<p class="MsoNormal"><span lang="EN-US">HPV</span>人乳头瘤病毒疫苗是全球第一个能预防癌症的疫苗，特别是能预防对女性健康影响极大的宫颈癌，所以市场需求一直很高，国内也经常缺货，现在默沙东公司表态今年将增加对中国市场的<span lang="EN-US">HPV</span>疫苗供应。</p>
<p class="MsoNormal"><span style="color:#ff0000;"><strong>据报道，生物医药企业默沙东表示，该企业对中国的<span lang="EN-US">HPV</span>疫苗供应量呈逐年增长态势，并将在<span lang="EN-US">2022</span>年大幅增加。</strong></span></p>
<p class="MsoNormal">据透露，默沙东还在积极开展临床试验，扩展<span lang="EN-US">HPV</span>疫苗的适应证，以期覆盖更多年龄层和人群，保护更多中国大众的健康。</p>
<p class="MsoNormal">根据医学资料，<span lang="EN-US">HPV</span>病毒有<span lang="EN-US">100</span>多种亚型，分为低危型和高危型，只有高危型<span lang="EN-US">HPV</span>的持续感染，才会进展为恶性病变。</p>
<p class="MsoNormal"><span lang="EN-US">HPV</span>病毒与宫颈癌之间具有高相关性。临床证明，<span lang="EN-US">99.7</span>％的宫颈癌都是<span lang="EN-US">HPV</span>病毒感染所引起，<strong>而宫颈癌是致死率仅次于卵巢癌的女性生殖道恶性肿瘤。我国妇女患宫颈癌的比例<span lang="EN-US">15/10</span>万，仅次于智利。</strong></p>
<p class="MsoNormal">此外，<span lang="EN-US">HPV</span>病毒还与<span lang="EN-US">85-90</span>％的肛门癌、<span lang="EN-US">70-75</span>％的阴道癌、<span lang="EN-US">30</span>％的外阴癌密切相关。</p>
<p class="MsoNormal">目前国内上市的<span lang="EN-US">HPV</span>疫苗中，主要有葛兰素史克生产的<span lang="EN-US">2</span>价<span lang="EN-US">HPV</span>（<span lang="EN-US">HPV16</span>、<span lang="EN-US">18</span>型）疫苗希瑞适、由默沙东研发生产和智飞生物代理的<span lang="EN-US">4</span>价<span lang="EN-US">HPV</span>（<span lang="EN-US">HPV6</span>、<span lang="EN-US">11</span>、<span lang="EN-US">16</span>、<span lang="EN-US">18</span>型）疫苗佳达修和<span lang="EN-US">9</span>价<span lang="EN-US">HPV</span>（<span lang="EN-US">HPV6</span>、<span lang="EN-US">11</span>、<span lang="EN-US">16</span>、<span lang="EN-US">18</span>、<span lang="EN-US">31</span>、<span lang="EN-US">33</span>、<span lang="EN-US">45</span>、<span lang="EN-US">52</span>、<span lang="EN-US">58</span>型）疫苗佳达修<span lang="EN-US">9</span>疫苗，以及国内生产厂家万泰生物的<span lang="EN-US">2</span>价<span lang="EN-US">HPV</span>（<span lang="EN-US">HPV16</span>、<span lang="EN-US">18</span>型）疫苗馨可宁。</p>
<p class="MsoNormal">默沙东公司是少有的能提供<span lang="EN-US">9</span>价<span lang="EN-US">HPV</span>疫苗的公司之一，国产上市的主要是<span lang="EN-US">2</span>价<span lang="EN-US">HPV</span>疫苗，不过国内有<span lang="EN-US">14</span>价<span lang="EN-US">HPV</span>疫苗在试验中。</p>
<p class="MsoNormal">目前<span lang="EN-US">2</span>价<span lang="EN-US">HPV</span>疫苗对宫颈癌的保护性在<span lang="EN-US">70%</span>；<span lang="EN-US">9</span>价<span lang="EN-US">HPV</span>疫苗增加了<span lang="EN-US">5</span>个高危致癌的<span lang="EN-US">HPV</span>病毒型（另<span lang="EN-US">2</span>个为不引起癌症的<span lang="EN-US">HPV 6</span>型和<span lang="EN-US">11</span>型），其对宫颈癌的保护性大约在<span lang="EN-US">90%</span>。</p>

<p class="MsoNormal" style="text-align: center;"><img alt="首个预防癌症的疫苗 默沙东确认2022年增加中国市场HPV疫苗供应" h="399" src="https://img1.mydrivers.com/img/20220111/d59a6e9e-c224-4cb5-8e1b-412ea8fbcf9c.png" style="text-align: center; border: 1px solid black;" w="600" referrerpolicy="no-referrer"></p>

           
           
<p class="end"> - THE END -</p> 
          <p class="zhuanzai">转载请注明出处：快科技</p>  
 <p class="bqian"><a href="https://news.mydrivers.com/tag/yimiao.htm"><i>#</i>疫苗</a><a href="https://news.mydrivers.com/tag/aizheng.htm"><i>#</i>癌症</a></p>
<p class="url">
     
<span>责任编辑：宪瑞</span>
</p>
        
</div>
            